drugdevelopment-technology.com Report : Visit Site

Technical data of the drugdevelopment-technology.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host drugdevelopment-technology.com. Currently, hosted in United States and its service provider is Amazon Technologies Inc. .

the related websites

2020health.org rba.co.uk biomedcentral.com pharmweb.net cri.org.uk norml.org dailymail.co.uk bbc.com sildenafil-low-price.com telegraph.co.uk aidsmap.com nice.org.uk 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

- the leading site for news and procurement in the drug development industry " / -- -- is using cookies we use them to give you the best experience. if you continue using our website, we'll assume that you are happy to receive all cookies on this website. continue learn more x x advertise with us search -- search log in log in register market & customer insight register advertise with us home news advertise with us company a-z analysis about us products & services comment pharma technology focus magazine company releases projects about us online white papers events contact us videos apis apis projects analysis news suppliers white papers videos comment comment vaccine development: the need for speed comment lack of cmo availability threatens cell and gene therapy development comment novaliq’s novatears+omega-3 represents the first-in-class omega-3-containing eye drop for evaporative dry eye approvals approvals projects analysis news suppliers white papers videos comment analysis july’s top news stories news ema issues positive opinion on biomarker for parkinson’s trials analysis june’s top news stories clinical research clinical research projects analysis news suppliers white papers videos comment analysis july’s top news stories analysis june’s top news stories comment new drugs and therapeutic options help the immune system fight cancer clinical trials clinical trials projects analysis news suppliers white papers videos comment news eyenovia announces positive results of eyn pg21 clinical trial news janssen reports positive topline data from atlas trial for hiv-1 news novocure and us oncology research partner for panova-3 trial diseases diseases projects analysis news suppliers white papers videos comment analysis june’s top news stories comment roche’s tecentriq threatens bms’ opdivo in small cell lung cancer market comment the challenges of using stem cells in neurology genomics & proteomics genomics & proteomics projects analysis news suppliers white papers videos comment analysis july’s top news stories analysis june’s top news stories analysis may’s top news stories market data market data projects analysis news suppliers white papers videos comment news deals this week: impact therapeutics, sienna biopharmaceuticals, advanced proteome therapeutics analysis july’s top news stories news deals this week: savara, tiziana life sciences, verastem technology technology projects analysis news suppliers white papers videos comment analysis july’s top news stories news genentech doses first patient in perjeta and herceptin phase 3 study news combining antibiotics with immune response to treat antibiotic resistant bacteria all all sections home news advertise with us company a-z analysis about us products & services comment pharma technology focus magazine company releases projects about us online white papers events contact us videos trending: clinical trials technology technology combining antibiotics with immune response to treat antibiotic resistant bacteria by allie nawrat researchers from lehigh university in the us have designed a new possible solution for antibiotic resistant bacteria by combining antibiotics... clinical research the challenges of using stem cells in neurology approvals hemlibra® (emicizumab-kxwh) for the treatment of haemophilia a with inhibitors clinical trials another bace inhibitor fails in phase iii trials diseases abivax believes it has made progress towards hiv cure technology emulate and astrazeneca announce organs-on-chips partnership clinical trials cbd shown to reduce number of seizures in epilepsy patients latest news news -- eyenovia announces positive results of eyn pg21 clinical trial 16 august 2018 -- news -- janssen reports positive topline data from atlas trial for hiv-1 16 august 2018 -- news -- novocure and us oncology research partner for panova-3 trial 16 august 2018 -- load more news -- get important industry news and analysis sent to your inbox – sign up to our e-newsletter here comment expert commentary & analysis from globaldata 6 aug analysis july’s top news stories 5 jul analysis june’s top news stories 27 jun comment will tumor-agnostic drug development help accelerate precision medicine approaches? 26 jun comment new drugs and therapeutic options help the immune system fight cancer view all comment most read deals this week: impact therapeutics, sienna biopharmaceuticals, advanced proteome therapeutics deals this week: savara, tiziana life sciences, verastem m&as this week: wirb-copernicus, abcellera biologics, apricus biosciences genentech doses first patient in perjeta and herceptin phase 3 study ultragenyx doses first patient in dtx401 phase 1/2 study to treat gsdia company releases press release characterising liposomes using multi-angle dls liposomes are nowadays frequently used as drug delivery systems, and as such requires that they are well characterised for manufacturing... malvern panalytical malvern panalytical’s august and september webinars and seminars press release metrohm acquire’s b&w tek’s spectroscopy business to develop raman products switzerland-based chemical analysis products manufacturer metrohm and us-based raman spectroscopy equipment supplier b&w; tek have announced the acquisition of b&w...; b&w tek pre-clinical and clinical studies in dermatology press release intravital visualisation of the dynamic changes in human hair follicle cycling monasterium laboratory’s scientists have published a new article in the british journal of dermatology on... company whitepapers quick and flexible elemental screening with omnian malvern panalytical detecting the presence of trace polymorphs and impurities malvern panalytical getting acquainted with the theory of xrf malvern panalytical application: operating reactor systems for process research and development systag systems technik analysing the effect of test compounds in ex vivo culture assays monasterium laboratory state-of-the-art skin and hair research preclinical and clinical services monasterium laboratory flexypat as a calorimeter systag systems technik company a-z more fleet bioprocessing immunoassay development and bioconjugation synex synthetics custom synthesis and contract research and development icdd translatable mitochondria testing for drug safety and efficacy immunxperts immunology services for drug development acps customised services for the clinical development of new drug substances and drug products monasterium laboratory contract research and preclinical services for dermatology immunoprecise antibodies custom therapeutic monoclonal antibody development ika-werke drug processing technology and laboratory equipment pfanstiehl injectable and hple carbohydrates for protein stabilisation and optimisation piramal pharma solutions integrated contract pharmaceutical development, clinical services and commercial manufacturing charles ischi medication testing solutions for drug development malvern panalytical biopharmaceutical and drug development biovian contract manufacturing of biopharmaceuticals systag systems technik automation systems for small-molecule drug and api development b&w tek raman spectroscopy for laboratory analysis and process applications emisphere technologies drug delivery development for advanced oral formulations gamlen instruments benchtop tablet manufacture instruments, research analysers, and formulation training for drug development pharmatest services research models to evaluate drug candidate efficacy pharmaceutical development group pharmaceutical regulatory consultant and fda regulatory strategist successful strategies international customized project management and leadership development courses read our magazine pharma technology focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format. read online send me notifications of new

URL analysis for drugdevelopment-technology.com

https://www.drugdevelopment-technology.com/news/janssen-reports-positive-topline-data-atlas-trial-hiv-1/
https://www.drugdevelopment-technology.com/technology
https://www.drugdevelopment-technology.com/contractors/lab_equipment/ika-werke/
https://www.drugdevelopment-technology.com/downloads/whitepapers/delivery/flexypat-calorimeter/
https://www.drugdevelopment-technology.com/./news/clinical-research
https://www.drugdevelopment-technology.com/projects/palynziq-pegvaliase-pqpz-for-the-treatment-of-adults-with-phenylketonuria/
https://www.drugdevelopment-technology.com/projects/hemlibra-emicizumab-kxwh-treatment-haemophilia-inhibitors/
https://www.drugdevelopment-technology.com/videos/approvals
https://www.drugdevelopment-technology.com/news/company-news/mas-week-nabriva-therapeutics-sangamo-therapeutics-ryboquin/
https://www.drugdevelopment-technology.com/contractors/contract_research/monasterium-laboratory/
https://www.drugdevelopment-technology.com/news/cbd-shown-reduce-number-seizures-epilepsy-patients/
https://www.drugdevelopment-technology.com/./comment/approvals
https://www.drugdevelopment-technology.com/company-a-z
https://www.drugdevelopment-technology.com/news/rafael-activates-new-site-phase-trial-cpi-613-bendamustine/
https://www.drugdevelopment-technology.com/./features/clinical-trials
verdict.co.uk

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: DRUGDEVELOPMENT-TECHNOLOGY.COM
Registry Domain ID: 95868095_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.lcn.com
Registrar URL: https://www.lcn.com
Updated Date: 2017-06-13T09:56:17+01:00
Creation Date: 2003-03-17T11:35:42+00:00
Registrar Registration Expiration Date: 2019-03-17T10:35:42+00:00
Registrar: LCN.com Ltd
Registrar IANA ID: 602
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +44.1438342490
Domain Status: clientDeleteProhibited
Domain Status: clientTransferProhibited
Domain Status: clientUpdateProhibited
Registry Registrant ID:
Registrant Name: PDMG Plc IT Department
Registrant Organisation: Progressive Digital Media Group PLC
Registrant Street: John Carpenter House
Registrant Street: John Carpenter Street
Registrant City: London
Registrant State: London
Registrant Postal Code: EC4Y 0AN
Registrant Country: GB
Registrant Phone: +44.2079367923
Registrant Email: [email protected]
Registry Admin ID:
Admin Name: PDMG Plc IT Department
Admin Organisation: Progressive Digital Media Group PLC
Admin Street: John Carpenter House
Admin Street: John Carpenter Street
Admin City: London
Admin State: London
Admin Postal Code: EC4Y 0AN
Admin Country: GB
Admin Phone: +44.2079367923
Admin Email: [email protected]
Registry Tech ID: AI-300624
Tech Name: LCN Hostmaster
Tech Organization: LCN.com Ltd
Tech Street: Units H, J, K, Gateway 1000, Whittle Way
Tech City: Stevenage
Tech State/Province: Herts
Tech Postal Code: SG1 2FP
Tech Country: GB
Tech Phone: +44.1438342490
Tech Fax: +44.1438300137
Tech Email: [email protected]
Name Server: ns.tmnplc.com
Name Server: ns3.tmngroup.com
Name Server: ns4.tmngroup.com
Name Server: ns2.tmnplc.com
DNSSec: Unsigned
URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
>>> Last update of WHOIS database: 2017-06-13T09:56:17+01:00 <<<

Domain Registration Service Provided By: LCN.com

The data in LCN.com's WHOIS database is provided by LCN.com for information
purposes, and to assist persons in obtaining information about or related to a
domain name registration record. LCN.com does not guarantee its accuracy.

By submitting a WHOIS query, you agree that you will use the data obtained only
for lawful purposes and that, under no circumstances will you use this data to:

(a) allow, enable, or otherwise support the transmission by e-mail, telephone,
or facsimile of mass, unsolicited, commercial advertising or solicitations to
entities other than the data recipient's own existing customers; or (b) enable
high volume, automated, electronic processes that send queries or data to the
systems of LCN.com, except as reasonably necessary to register domain names or
modify existing registrations.

By submitting this query, you agree to abide by this policy.

LCN.com reserves the right to modify these terms at any time.


*******************************************************************************
*******************************************************************************
** **
** Domain Registration Service Provided By: LCN.com **
** ------------------------------------------------ **
** **
** **
** - For award winning domain name services visit: **
** **
** https://www.lcn.com/domain_names **
** **
** - For powerful & reliable web hosting backed by a 30 day money **
** backed guarantee visit: **
** **
** https://www.lcn.com/web_hosting **
** **
** - For support visit: **
** **
** https://www.lcn.com/contact_us **
** **
*******************************************************************************
*******************************************************************************

  REGISTRAR LCN.COM LTD.

  REFERRER http://www.LCN.com

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =drugdevelopment-technology.com

  PORT 43

  SERVER whois.lcn.com

  ARGS drugdevelopment-technology.com

  PORT 43

  TYPE domain

DOMAIN

  NAME drugdevelopment-technology.com

NSERVER

  NS.TMNPLC.COM 91.208.117.43

  NS2.TMNPLC.COM 91.208.117.43

  NS3.TMNGROUP.COM (DOES NOT EXIST)

  NS4.TMNGROUP.COM (DOES NOT EXIST)

STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited

  CHANGED 2012-12-24

  CREATED 2003-03-17

  EXPIRES 2019-03-17

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .